Last update:
Vaccination news
Oncology & Cancer
Q&A: When will patients see personalized cancer vaccines?
Catherine Wu has been a pioneer in a promising approach to fight cancer: vaccines that target specific immune-stimulating molecules, known as immunogenic peptides, generated by the distinct genetic mutations of any individual ...
2 hours ago
0
0
Why some adults may need another dose of measles vaccine
A rising number of measles cases in the U.S. this year is raising concerns over a comeback of a disease that was declared eliminated in this country 24 years ago.
23 hours ago
0
0
New vaccine strategy may mean the end of the line for endless boosters
Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
Apr 15, 2024
0
102
Breakthrough aerosol human infection model gives hope for future TB vaccine development
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs—the way TB enters the body.
Apr 15, 2024
0
9
Having options can lower vaccine hesitancy, finds research
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
Q&A: Does the HPV vaccine protect against cancers and genital warts?
Every year in the U.S., human papillomavirus (HPV) causes about 37,000 new cases of cancer. These are cancers that could have been prevented with the HPV vaccine.
Apr 15, 2024
0
1
Czech whooping cough spread accelerates, three dead
The Czech Republic has been hit by a soaring number of whooping cases and the fast growing outbreak has killed three people, health authorities said on Monday.
Apr 15, 2024
0
0
Nigeria first to use 'revolutionary' meningitis jab: WHO
Africa's most populous nation Nigeria has launched a "revolutionary" vaccine against meningitis, in what the World Health Organization (WHO) on Friday said was a world first.
Apr 13, 2024
0
0
Chlamydia vaccine shows promise in early trial
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
New insights on B cells: Researchers explore building better antibodies and curbing autoimmune diseases
Four new studies led by Harvard Medical School researchers at Boston Children's Hospital reveal details about how B cells in the immune system churn out antibodies that become increasingly potent and specific after we're ...
Apr 12, 2024
0
27
Study suggests staying current with COVID-19 vaccinations helps combat emerging variants
New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.
Apr 12, 2024
0
47
COVID-19 vaccine effectiveness: Results from Norway demonstrate the reproducibility of federated analytics
Researchers from NDORMS and the University of Oslo have successfully replicated findings from recently published international studies on the effectiveness of COVID-19 vaccines to prevent long COVID and post-acute complications.
Apr 11, 2024
0
19
From RSV to meningococcal B, we must ensure equitable access to childhood immunizations
As we look towards the peak season for respiratory viruses, the announcement of new respiratory syncytial virus (RSV) immunization programs for children in a number of Australian states is welcome news.
Apr 11, 2024
0
1
US measles cases are up in 2024. What's driving the increase?
Measles outbreaks in the U.S. and abroad are raising health experts' concern about the preventable, once-common childhood virus.
Apr 11, 2024
1
0
ChatGPT could help reduce vaccine hesitancy and provide helpful advice on STIs
New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine ...
Apr 10, 2024
0
0
Adding vaccine to immunotherapy for liver cancer shows promise in early trial
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Apr 9, 2024
0
64
Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers
TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous cell cancer (HNSCC), according ...
Apr 9, 2024
0
14
Understanding the link between family physician characteristics and COVID-19 vaccination gaps
New research examining the characteristics of physicians with the largest share of patients unvaccinated against SARS-CoV-2 may help increase vaccination rates going forward. The study, published in CMAJ (Canadian Medical ...
Apr 8, 2024
0
1
Disease severity similar for RSV as unvaccinated COVID-19, influenza
Disease severity is similar for patients hospitalized with respiratory syncytial disease (RSV) and unvaccinated adults with COVID-19 or influenza, according to a study published online April 4 in JAMA Network Open.
Apr 8, 2024
0
1
